Prenat Diagn

. 2024 Jun 11.

 doi: 10.1002/pd.6622. Online ahead of print. https://pubmed.ncbi.nlm.nih.gov/38862387/

Exome sequencing in fetuses with congenital diaphragmatic hernia in a nationwide cohort

Katinka Weller ¹, Dineke Westra ², Nina C J Peters ¹, Martina Wilke ³, Diane Van Opstal ³, Ilse Feenstra ², Joris van Drongelen ⁴, Alex J Eggink ¹, Karin E M Diderich ³, Philip L J DeKoninck ¹

Affiliations expand

• PMID: 38862387
• DOI: 10.1002/pd.6622

Abstract

Objective: To evaluate the diagnostic yield of exome sequencing (ES) in fetuses and neonates with prenatally detected congenital diaphragmatic hernia (CDH) and normal copy number variant (CNV) analysis.

Methods: We conducted a retrospective cohort study of prenatally diagnosed CDH cases seen between 2019 and 2022. All cases who underwent prenatal or postnatal genetic testing were reviewed. The results from the ES analysis that identified pathogenic or likely pathogenic single nucleotide variants are described.

Results: In total, 133 fetuses with CDH were seen, of whom 98 (74%) had an isolated CDH and 35 (26%) had a complex CDH (associated structural anomalies) on prenatal examination. ES was performed in 68 cases, and eight pathogenic or likely pathogenic variants were found, accounting for a 12% diagnostic yield (10% [5/50] in isolated cases and 17% [3/18] in complex CDH).

Conclusions: In 12% of fetuses and neonates with CDH and normal CNV analysis results, pathogenic or likely pathogenic variants were identified with ES. These data indicate that there is a substantial diagnostic yield when offering ES in prenatally detected CDH, both in complex and isolated cases.

© 2024 The Author(s). Prenatal Diagnosis published by John Wiley & Sons Ltd.